Connect to other sites within the UBM Medica Network
Lung Cancer Screening Guidelines Exclude Patients
Changing smoking habits may require more sensitive lung cancer screening criteria to include as many high-risk individuals as possible.
CMS Issues Final LDCT Coverage Decision
CMS released their final decision for lung cancer screening with low-dose CT.
Lung Cancer and Diabetes: A Complex Affair
A new study clarifies the link between metformin and lung cancer. Perhaps not surprisingly, a smoking habit (or lack of it) substantially affects risk.
Data Backs CT Lung Screening in More High-Risk Patients
NCCN Group 2 high-risk patients to benefit from CT lung screening, study says.
LDCT for Lung Cancer Screening: The Effect of False-Positives
Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.
What Really Works for Tough-to-Treat NSCLC?
Epidermal growth factor receptor tyrosine kinase inhibitors may not be the best option for some patients with nonsmall cell lung cancer, but an ALK inhibitor, crizotinib, proves a winner.
Phase III Immunotherapy Lung Cancer Trial Stopped Early
GlaxoSmithKline has stopped a phase III trial of a novel lung cancer immunotherapeutic agent, after determining that it may not be possible to identify which genetic subgroups may benefit from the treatment.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.